Clinical Trials Logo

Clinical Trial Summary

Morbid obesity has become a major global health problem, and the use of bariatric surgery is increasing. One common complication seen following bariatric surgery is the formation of gallstones. Contributing factors to gallstone formation include hypomotility of gall bladder and supersaturation of bile due to rapid weight loss and mobilization of cholesterol. Previous studies revealed oral probiotics could reduce the cholesterol level by as much as 22% to 33%. The possible mechanisms included bile salt hydrolase activity, assimilation of cholesterol by the bacteria, binding of cholesterol to the bacterial cell wall and physiological actions of the end products of short chain fatty acid fermentation. Therefore, the aim of this study was to determine the ability of probiotics to prevent gallstones formation after bariatric surgery and to evaluate the impact of oral administration of probiotics on the post bariatric surgery patients 's quality of life.

Gastrointestinal Quality of Life Index is a widely accepted questionnaire for evaluating the quality of life for patients receiving bariatric surgery. It consists of five domains: digestive symptoms; physical function; emotional condition; social condition and effect of medical treatment, which could access the quality of life of bariatric patient effectively and completely.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03247101
Study type Interventional
Source Min-Sheng General Hospital
Contact
Status Active, not recruiting
Phase N/A
Start date February 2016
Completion date December 2017

See also
  Status Clinical Trial Phase
Completed NCT01625026 - Obeticholic Acid in Bariatric and Gallstone Disease Phase 2
Completed NCT00530998 - Minimally Invasive Surgery: Using Natural Orfices
Completed NCT02858986 - 3D Versus 4K Laparoscopic Cholecystectomy N/A
Active, not recruiting NCT05592795 - Explore the Effects and Mechanisms of ERCP and EST on Biliary Microecology
Terminated NCT02325492 - Medical Dissolution of Cholesterol Gallstones Using Oral Aramchol - A Proof of Concept Phase IIa Study Phase 2
Completed NCT02469935 - Accuracy of Surgeon-performed Ultrasound in Detecting Gallstones - a Validation Study N/A
Withdrawn NCT01232959 - Feasibility of Transvaginal Cholecystectomy N/A
Completed NCT01190280 - Indications for Gallbladder Surgery in Gallstone Disease Phase 3
Withdrawn NCT00460980 - Effect of Virtual Reality Training by Novices on Laparoscopic Cholecystectomy in a Porcine Model N/A
Completed NCT02344654 - Fluorescence Cholangiography During Cholecystectomy - a RCT N/A
Completed NCT00528632 - Gallbladder Cholesterolosis, Body Mass Index and Serum Cholesterol and Triglycerides N/A
Recruiting NCT03891147 - A Clinical Trial of Electro-acupuncture for Treating Gallstone Diseases N/A
Not yet recruiting NCT06385860 - Prediction Model for Early Biliary Stasis After Bariatric Surgery
Recruiting NCT02831556 - Point of Care 3D Ultrasound for Various Applications: A Pilot Study
Completed NCT02947256 - Laparoscopic Cholecystectomy With Retro-infundibular Approach Phase 2
Recruiting NCT01438385 - Interventional Endoscopy Database for Pancreatico-biliary, Gastrointestinal and Esophageal Disorders N/A
Completed NCT01410734 - Fluorescence Imaging on the da Vinci Surgical System for Intra-operative Near Infrared Imaging of the Biliary Tree (up to 2-weeks Post-operatively) N/A
Withdrawn NCT00240123 - Effect of Benadryl Sedation During ERCP or EUS Phase 1
Completed NCT03809559 - Repeatability and Reproducibility of Quantitative MRCP
Recruiting NCT01822262 - Contrastive Study for Minimally Invasive Cholecystolithotomy With Gallbladder Reservation and Laparoscopic Cholecystectomy Phase 4